Authors: Kelly Y. Kim
Addresses: The George Washington University, 805 21st St, NW, Suite 601, Washington, DC 20052, USA
Abstract: This paper examined the impact of strategic R&D alliances on biomedical product innovation by small biotechnology firms in the USA. Inferential statistics involving logistic regression modelling was applied to analyse the influence of different types of collaborators on innovation success. The results showed that for start-up companies, an increase in the number of corporate partners was both positively and significantly associated with the firms' innovation success, as measured by successful product development to the commercialisation stage, but such relationship did not hold for older firms. Moreover, an increase in the number of alliances with universities had no statistically significant association with an improvement in the innovation performance of start-ups nor of older firms. These findings may help inform alliance management by technology managers as they assess and balance the composition of their network of R&D partners to optimise their strategic benefit.
Keywords: research and development; R&D; strategic alliances; product innovation; biotechnology industry; collaboration; partnerships; start-ups; biomedical products; small and medium-sized enterprises; SMEs; USA; United States; inferential statistics; logistic regression modelling; collaborators; innovation success; start-up companies; corporate partners; commercialisation; universities; higher education; innovation performance; older firms; alliance management; technology managers; network composition; strategic benefits; technology management.
International Journal of Technology Management, 2012 Vol.59 No.1/2, pp.116 - 138
Available online: 13 Jun 2012 *Full-text access for editors Access for subscribers Purchase this article Comment on this article